|
|
 Dr. Ingrid S. Sketris, PharmD, MPA(HSA)
College of Pharmacy
Dalhousie University
5968 College Street
Halifax , Nova Scotia B3H 3J5
E-mail: Ingrid.Sketris@dal.ca
Tel : (902) 494-3755 ; Fax : (902) 494-1396
Dr. Sketris is a Professor of the College of Pharmacy , School of Nursing , School of Health Services Administration , and Computer Science, and the Department of Community Health and Epidemiology, Dalhousie University . She is a graduate of the University of Toronto (BSc(Phm), 1977), University of Minnesota (PharmD, 1979), University of Tennessee, Centre for Health Sciences (Residency in Clinical Toxicology/Pharmacy Practice, 1980) and Dalhousie University (MPA(HSA) 1989). She is a fellow of the Canadian Society of Hospital Pharmacists and the American College of Clinical Pharmacy. Dr. Sketris is currently on the Editor ial Boards of the Canadian Journal of Clinical Pharmacology and Clinical Therapeutics. Dr. Sketris was a member of the Scientific Advisory Panel of the Canadian Coordinating Office for Health Technology Assessment from 1996 to1998 and of the Patented Medicine Prices Review Board from 1999 to 2004. She is currently a member of the CIHR Institute Advisory Board for Health Services and Policy Research. In June 2000, Dr. Sketris received a Chair in health services research focusing on pharmaceutical policy and utilization management from the Canadian Health Services Research Foundation (CHSRF) and the Canadian Institutes of Health Research (CIHR) cosponsored by the Nova Scotia Health Research Foundation. She and her colleagues at IMPART (Initiative for Medication Management, Policy Analysis, Research and Training) http://www.dal.ca/~impart/ conduct research related to medication management.
Selected Publications:
1. Sketris IS, Brown MG, Murphy AL. 2004. Policy Choices for Pharmacare: The Need to Examine Benefit Design, Medication Management Strategies and Evaluation. Health Care Papers 4(3):36-45.
2. Sketris IS, Bowles S, Manuel R. 2004. Canadian Public Polices and Practices Impacting Drug Prices, Utilization and Expenditures. J Pharmaceutical Finance, Economics and Policy; 12:1 23-54.
3. Sketris IS, Metge C, Shevchuk Y, Comeau DG, Kephart GC, Blackburn J, MacCara M, Laturnas A. 2004. Comparison of Anti-infective Drug Use in Elderly Persons in Manitoba , Nova Scotia , and Saskatchewan , Canada : Relationship to Drug Insurance Reimbursement Policies. American Journal of Geriatric Pharmacotherapy; 2(1): 24-35.
|